Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma
- PMID: 1314694
Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma
Abstract
We examined loss of heterozygosity (LOH) on all autosomal chromosomes in 53 non-small cell lung carcinomas. Frequent LOH was observed on the long arms of chromosomes 1 (37%), 2 (31%), 5 (30%), 8 (31%), and 13 (32%), and the short arms of chromosomes 3 (54%) and 17 (62%). LOH on chromosomes 3p and 17p was observed in all informative cases of squamous cell carcinoma, but was significantly less frequent in adenocarcinomas (P = 0.003 and 0.001, respectively). Similarly, LOH on chromosome 13q was observed frequently in squamous cell carcinomas (5 of 9 informative cases, or 56%), but in only 5 of 26, or 19%, of adenocarcinomas. In contrast, LOH on chromosome 2q was observed only in adenocarcinomas. In addition, this chromosomal arm was lost more frequently in poorly differentiated, compared to well differentiated adenocarcinomas. Furthermore, a correlation between fractional allelic loss and pathohistological grade was identified. These results implicate the presence of several tumor suppressor genes associated with development and/or progression of non-small cell lung carcinomas.
Similar articles
-
Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung.Cancer Res. 1994 Nov 1;54(21):5652-5. Cancer Res. 1994. PMID: 7923212
-
Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung.Cancer Res. 1992 Feb 15;52(4):873-7. Cancer Res. 1992. PMID: 1346586
-
Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma.Respir Med. 2005 Mar;99(3):308-12. doi: 10.1016/j.rmed.2004.08.008. Respir Med. 2005. PMID: 15733506
-
Polygenic resistance to mouse pulmonary adenomas.Exp Lung Res. 2000 Dec;26(8):617-25. doi: 10.1080/01902140150216701. Exp Lung Res. 2000. PMID: 11195459 Review.
-
Global analysis of chromosome 1 genes among patients with lung adenocarcinoma, squamous carcinoma, large-cell carcinoma, small-cell carcinoma, or non-cancer.Cancer Metastasis Rev. 2015 Jun;34(2):249-64. doi: 10.1007/s10555-015-9558-0. Cancer Metastasis Rev. 2015. PMID: 25937073 Review.
Cited by
-
The genetic analysis of ovarian cancer.Br J Cancer. 1995 Sep;72(3):521-7. doi: 10.1038/bjc.1995.367. Br J Cancer. 1995. PMID: 7669555 Free PMC article. Review. No abstract available.
-
Differences of E-cadherin expression levels and patterns in primary and metastatic human lung cancer.Clin Exp Metastasis. 1994 Jan;12(1):55-62. doi: 10.1007/BF01784334. Clin Exp Metastasis. 1994. PMID: 8287621
-
Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer.Cell. 1997 Mar 21;88(6):747-56. doi: 10.1016/s0092-8674(00)81921-2. Cell. 1997. PMID: 9118218 Free PMC article.
-
Topographical distributions of allelic loss in individual non-small-cell lung cancers.Am J Pathol. 2000 Sep;157(3):985-93. doi: 10.1016/S0002-9440(10)64611-1. Am J Pathol. 2000. PMID: 10980137 Free PMC article.
-
Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16.Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9451-5. doi: 10.1073/pnas.91.20.9451. Proc Natl Acad Sci U S A. 1994. PMID: 7937788 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical